IGC Pharma, Inc. (IGC) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, IGC Pharma, Inc. (NYSE:IGC) is held by 7 institutional firms.

• These investors collectively held 1.4% of the company's total shares outstanding in December 2025, down from 5.9% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 7.70%, with a year-over-year a decrease of 76.67% in the count of filers.
• Among the 7 institutional holders of IGC Pharma, 2 added to their stakes while 0 trimmed their positions and 5 held steady.
• The total number of shares held by institutions in IGC Pharma increased to 1.28Mn as of December 2025, a net change of up by 91.82K shares quarter on quarter, and down 1.56Mn shares year over year.
• The top institutional stake in IGC Pharma as of December 31, 2025 belongs to VANGUARD GROUP INC, which owns 1.15Mn shares, or 1.26% of the company.
• Among the most significant buyers of IGC Pharma during December 2025 were LAWOOD & CO (75.00K), UBS Group AG (16.82K).
• The top 7 institutional holders of IGC Pharma for the quarter ending December 2025 included VANGUARD GROUP INC (1.15Mn), LAWOOD & CO (75.00K), TRUIST FINANCIAL CORP (36.67K), UBS Group AG (19.87K), Geneos Wealth Management Inc. (3.00K), Farther Finance Advisors, LLC (100), DHJJ Financial Advisors, Ltd. (80).